Daigaku Uchida

1.4k total citations
39 papers, 950 citations indexed

About

Daigaku Uchida is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Daigaku Uchida has authored 39 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Daigaku Uchida's work include Neuropeptides and Animal Physiology (10 papers), Diabetes Treatment and Management (8 papers) and Pituitary Gland Disorders and Treatments (7 papers). Daigaku Uchida is often cited by papers focused on Neuropeptides and Animal Physiology (10 papers), Diabetes Treatment and Management (8 papers) and Pituitary Gland Disorders and Treatments (7 papers). Daigaku Uchida collaborates with scholars based in Japan, United States and Serbia. Daigaku Uchida's co-authors include Akira Arimura, Ichiro Tatsuno, Tomoaki Tanaka, Seiji Shioda, Anikó Somogyvári-Vigh, William A. Banks, Aizan Hirai, Yoshihiko Noguchi, Yasushi Saitō and Susumu Nakamura and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Scientific Reports.

In The Last Decade

Daigaku Uchida

39 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daigaku Uchida Japan	18	460	415	266	247	104	39	950
Dennis K. Lee Canada	13	739 1.6×	516 1.2×	266 1.0×	817 3.3×	182 1.8×	17	1.8k
Elena Deliu United States	15	183 0.4×	396 1.0×	170 0.6×	83 0.3×	123 1.2×	22	948
Ralf Paschke Germany	25	361 0.8×	943 2.3×	477 1.8×	101 0.4×	271 2.6×	35	1.4k
S. Heisler Canada	16	222 0.5×	380 0.9×	150 0.6×	73 0.3×	110 1.1×	42	756
Liliana G. Bianciotti Argentina	17	197 0.4×	337 0.8×	99 0.4×	121 0.5×	249 2.4×	82	1.0k
Jyoti Disa United States	20	386 0.8×	495 1.2×	155 0.6×	270 1.1×	184 1.8×	36	1.2k
Balázs Borsiczky Hungary	16	292 0.6×	244 0.6×	53 0.2×	197 0.8×	51 0.5×	25	599
Afaf Absood United States	17	607 1.3×	387 0.9×	100 0.4×	366 1.5×	131 1.3×	30	984
Zuo‐Ying Hu China	13	130 0.3×	189 0.5×	121 0.5×	136 0.6×	39 0.4×	43	707
Ann‐Cathrine Jönsson‐Rylander Sweden	14	176 0.4×	357 0.9×	177 0.7×	251 1.0×	74 0.7×	26	911

Countries citing papers authored by Daigaku Uchida

Since Specialization

Citations

This map shows the geographic impact of Daigaku Uchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daigaku Uchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daigaku Uchida more than expected).

Fields of papers citing papers by Daigaku Uchida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daigaku Uchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daigaku Uchida. The network helps show where Daigaku Uchida may publish in the future.

Co-authorship network of co-authors of Daigaku Uchida

This figure shows the co-authorship network connecting the top 25 collaborators of Daigaku Uchida. A scholar is included among the top collaborators of Daigaku Uchida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daigaku Uchida. Daigaku Uchida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Ai, et al.. (2024). Semaglutide improves treatment satisfaction and eating behaviour in Japanese patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 26(10). 4787–4790. 3 indexed citations

Ishii, Hitoshi, Hiroki Nakajima, Nozomu Kamei, et al.. (2021). Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study. Diabetes Therapy. 12(2). 595–611. 7 indexed citations

Ishibashi, Ryoichi, Atsuko Watanabe, Tetsuya Yamamoto, et al.. (2021). Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial. Diabetes Therapy. 12(5). 1415–1427. 6 indexed citations

Watanabe, Yasuhiro, Daisuke Suzuki, Nobuichi Kuribayashi, et al.. (2021). A randomized controlled trial of two diets enriched with protein or fat in patients with type 2 diabetes treated with dapagliflozin. Scientific Reports. 11(1). 11350–11350. 5 indexed citations

Ishibashi, Ryoichi, Tetsuya Yamamoto, Susumu Nakamura, et al.. (2020). Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan. Diabetes Therapy. 12(1). 453–460. 5 indexed citations

Koshizaka, Masaya, Ko Ishikawa, Takahiro Ishikawa, et al.. (2017). Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study). BMJ Open. 7(5). e015766–e015766. 4 indexed citations

Kawata, Takayuki, Masao Daimon, Rei Hasegawa, et al.. (2013). Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease. Cardiovascular Diabetology. 12(1). 121–121. 36 indexed citations

Suzuki, Sawako, Daigaku Uchida, Hisashi Koide, et al.. (2008). Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s). Peptides. 29(10). 1767–1772. 6 indexed citations

Suzuki, Sawako, Daigaku Uchida, Hisashi Koide, et al.. (2008). A possible association between aldosterone response to vasopressin and circadian change of aldosterone in the patients with aldosterone-producing adenoma. Peptides. 29(12). 2225–2231. 4 indexed citations

10.

Banks, William A., Daigaku Uchida, Akira Arimura, Anikó Somogyvári-Vigh, & Seiji Shioda. (2006). Transport of Pituitary Adenylate Cyclase-Activating Polypeptide Across the Blood-Brain Barrier and the Prevention of Ischemia-Induced Death of Hippocampal Neurons. Annals of the New York Academy of Sciences. 805(1). 270–277. 48 indexed citations

11.

Tatsuno, Ichiro, Tomoaki Tanaka, Daigaku Uchida, et al.. (2006). Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is a Regulator of Astrocytes: PACAP Stimulates Proliferation and Production of Interleukin 6 (IL-6), but not Nerve Growth Factor (NGF), in Cultured Rat Astrocyte. Annals of the New York Academy of Sciences. 805(1). 482–488. 20 indexed citations

12.

Kawata, Takayuki, Masao Daimon, Rei Hasegawa, et al.. (2006). Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist. American Heart Journal. 151(4). 798.e9–798.e15. 34 indexed citations

13.

Nakamura, Susumu, Tomoaki Tanaka, Daigaku Uchida, et al.. (2003). Rat cerebral endothelial cells express trk C and are regulated by neurotrophin-3. Biochemical and Biophysical Research Communications. 305(2). 400–406. 24 indexed citations

14.

Tatsuno, Ichiro, Daigaku Uchida, Tomoaki Tanaka, et al.. (2003). Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH‐independent macronodular adrenocortical hyperplasia. Clinical Endocrinology. 60(2). 192–200. 29 indexed citations

15.

Uchida, Daigaku, Ichiro Tatsuno, Tomoaki Tanaka, et al.. (1998). Maxadilan Is a Specific Agonist and Its Deleted Peptide (M65) Is a Specific Antagonist for PACAP Type 1 Receptor. Annals of the New York Academy of Sciences. 865(1). 253–258. 60 indexed citations

16.

Tanaka, Tomoaki, Ichiro Tatsuno, Yoshihiko Noguchi, et al.. (1998). Activation of Cyclin-dependent Kinase 2 (Cdk2) in Growth-stimulated Rat Astrocytes. Journal of Biological Chemistry. 273(41). 26772–26778. 35 indexed citations

17.

Uchida, Daigaku. (1996). Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Research. 736(1-2). 280–286. 3 indexed citations

18.

Uchida, Daigaku, Akira Arimura, Anikó Somogyvári-Vigh, Seiji Shioda, & William A. Banks. (1996). Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Research. 736(1-2). 280–286. 179 indexed citations

19.

Shuto, Yujin, Daigaku Uchida, Haruo Onda, & Akira Arimura. (1996). Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain. Regulatory Peptides. 67(2). 79–83. 41 indexed citations

20.

Uchida, Daigaku, et al.. (1993). Possible Involvement of Hypersecretion of ADH in Hyponatremia in a Diabetic Patient Complicated with Severe Neuropathy. Hormone Research. 39(5-6). 247–252. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact